Summary
This paper discusses the development of an optogenetic inhibitor that can disrupt GαqGTP-PLCβ interactions, which are implicated in various diseases, and its potential applications in understanding and treating these diseases.
Categories
Alzheimer's disease: The paper discusses the role of GαqGTP-PLCβ interactions in Alzheimer's disease and the potential of their optogenetic inhibitor in treating this disease.
Cognitive function and memory: The paper discusses the role of GαqGTP-PLCβ interactions in cognitive function and memory, as they are implicated in diseases like Alzheimer's that affect these functions.
Cancer treatment and prevention: The paper discusses the role of GαqGTP-PLCβ interactions in cancer and the potential of their optogenetic inhibitor in treating this disease.
Depression: The paper discusses the role of GαqGTP-PLCβ interactions in depression and the potential of their optogenetic inhibitor in treating this disease.
Phototherapy: The paper discusses the use of optogenetics, a form of phototherapy, in disrupting GαqGTP-PLCβ interactions and its potential applications in treating various diseases.
Author(s)
S Ubeysinghe, D Kankanamge
Publication Year
2023
Related Publications
Alzheimer's disease
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- New strategies for neuroprotection in glaucoma, a disease that affects the central nervous system
- Phospholipase C families: Common themes and versatility in physiology and pathology
- Neurogenesis and specification of retinal ganglion cells
- Chronobioengineering indoor lighting to enhance facilities for ageing and Alzheimer's disorder
Cognitive function and memory
- Phototransduction by retinal ganglion cells that set the circadian clock
- The two‐process model of sleep regulation: a reappraisal
- Strange vision: ganglion cells as circadian photoreceptors
- Information processing in the primate retina: circuitry and coding
- Melanopsin-positive intrinsically photosensitive retinal ganglion cells: from form to function
Cancer treatment and prevention
- The end of night: searching for natural darkness in an age of artificial light
- Light during darkness and cancer: relationships in circadian photoreception and tumor biology
- Molecular regulations of circadian rhythm and implications for physiology and diseases
- Light pollution and cancer
- Phospholipase C families: Common themes and versatility in physiology and pathology
Depression
- The two‐process model of sleep regulation: a reappraisal
- Light therapy and Alzheimer's disease and related dementia: past, present, and future
- Melanopsin-expressing intrinsically photosensitive retinal ganglion cells in retinal disease
- Nocturnal light exposure impairs affective responses in a wavelength-dependent manner
- Photoreception for circadian, neuroendocrine, and neurobehavioral regulation
Phototherapy
- Phototransduction by retinal ganglion cells that set the circadian clock
- Strange vision: ganglion cells as circadian photoreceptors
- Function of human pluripotent stem cell-derived photoreceptor progenitors in blind mice
- Lux vs. wavelength in light treatment of Seasonal Affective Disorder
- Short‐wavelength enrichment of polychromatic light enhances human melatonin suppression potency